Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo.
about
Lipid Nanoparticle Delivery of siRNA to Osteocytes Leads to Effective Silencing of SOST and Inhibition of Sclerostin In Vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipid Nanoparticle Delivery of ...... ibition of Sclerostin In Vivo.
@en
Lipid Nanoparticle Delivery of ...... ibition of Sclerostin In Vivo.
@nl
type
label
Lipid Nanoparticle Delivery of ...... ibition of Sclerostin In Vivo.
@en
Lipid Nanoparticle Delivery of ...... ibition of Sclerostin In Vivo.
@nl
prefLabel
Lipid Nanoparticle Delivery of ...... ibition of Sclerostin In Vivo.
@en
Lipid Nanoparticle Delivery of ...... ibition of Sclerostin In Vivo.
@nl
P2093
P2860
P356
P1476
Lipid Nanoparticle Delivery of ...... ibition of Sclerostin In Vivo.
@en
P2093
Andrew Cottle
Genc Basha
Haitang Wang
Mina Ordobadi
Pieter R Cullis
Wilder R Scott
P2860
P356
10.1038/MTNA.2016.68
P577
2016-09-13T00:00:00Z